New Op-Ed from C4IP Co-Chairs Andrei Iancu and David Kappos: Proposed Drug Patent Reforms Would Do More Harm Than Good
C4IP Co-Chairs and former USPTO Directors Andrei Iancu and David Kappos recently published an opinion piece in RealClear Health highlighting the unintended consequences that would arise if the Medication Affordability and Patent Integrity Act (MAPIA) is passed by Congress and signed into law. Supporters of the bill argue that drug companies take advantage of a